Yes indeed TradingHault, so there should be, the need for new effective antibiotic treatments is becoming more important every day.
IMO most of the players at the meeting mentioned, will be well aware of Recce, and the old Chemeq. They will likely be keeping across developments.
I suspect the best outcome for Recce here will be to nail down a cornerstone investor, with very deep pockets.
Be watching with great interest.
GLTA
Cabe
Ann: Recce Meets Antibiotic Leaders to Explore Opportunities, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.030(7.14%) |
Mkt cap ! $112.7M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 42.0¢ | 37.0¢ | $77.62K | 193.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30531 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 49884 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |